Target
Retinoic acid receptor RXR-beta
Ligand
BDBM524176
Substrate
n/a
Meas. Tech.
FLIPR Assay
IC50
210±n/a nM
Citation
 Giovannini, RCeci, ADorner-Ciossek, CPfau, RWiedenmayer, D 4-pyrazin-2-ylmethyl-morpholine derivatives and the use thereof as medicament US Patent  US11166958 Publication Date 11/9/2021 
Target
Name:
Retinoic acid receptor RXR-beta
Synonyms:
NR2B2 | Nuclear receptor subfamily 2 group B member 2 | RXRB | RXRB_HUMAN | Retinoic acid receptor RXR-beta | Retinoid X receptor beta | Retinoid receptor
Type:
PROTEIN
Mol. Mass.:
56932.89
Organism:
Homo sapiens (Human)
Description:
ChEMBL_39045
Residue:
533
Sequence:
MSWAARPPFLPQRHAAGQCGPVGVRKEMHCGVASRWRRRRPWLDPAAAAAAAVAGGEQQTPEPEPGEAGRDGMGDSGRDSRSPDSSSPNPLPQGVPPPSPPGPPLPPSTAPSLGGSGAPPPPPMPPPPLGSPFPVISSSMGSPGLPPPAPPGFSGPVSSPQINSTVSLPGGGSGPPEDVKPPVLGVRGLHCPPPPGGPGAGKRLCAICGDRSSGKHYGVYSCEGCKGFFKRTIRKDLTYSCRDNKDCTVDKRQRNRCQYCRYQKCLATGMKREAVQEERQRGKDKDGDGEGAGGAPEEMPVDRILEAELAVEQKSDQGVEGPGGTGGSGSSPNDPVTNICQAADKQLFTLVEWAKRIPHFSSLPLDDQVILLRAGWNELLIASFSHRSIDVRDGILLATGLHVHRNSAHSAGVGAIFDRVLTELVSKMRDMRMDKTELGCLRAIILFNPDAKGLSNPSEVEVLREKVYASLETYCKQKYPEQQGRFAKLLLRLPALRSIGLKCLEHLFFFKLIGDTPIDTFLMEMLEAPHQLA
  
Inhibitor
Name:
BDBM524176
Synonyms:
US11166958, Example 9
Type:
Small organic molecule
Emp. Form.:
C17H19FN4O3
Mol. Mass.:
346.3562
SMILES:
CNC(=O)[C@@H]1CN(Cc2cnc(Oc3ccccc3F)cn2)CCO1 |r|
Structure:
Search PDB for entries with ligand similarity: